Outcomes and Therapeutic Management of Bladder Cancer
Material type: TextPublication details: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020Description: 1 electronic resource (120 p.)ISBN:- 9783039369348
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
E-Book | Directory of Open Access Books | Not For Loan |
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease.
Creative Commons
There are no comments on this title.